Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The FDA Issues a Statement That Including Coffee in California's Prop 65 is Misleading and Inaccurate

California's Prop 65 ruling on acrylamide in coffee could confuse the general public about the proven benefits of coffee. Doctors Chopra (Harvard Medical School) and Gruber (USC Norris Comprehensive Cancer Center) state that coffee reduces the risk of seven different types of cancer.


News provided by

Purity Coffee

Sep 01, 2018, 06:00 ET

Share this article

Share toX

Share this article

Share toX

Purity Coffee Logo
Purity Coffee Logo

GREENVILLE, S.C., Sept. 1, 2018 /PRNewswire-PRWeb/ -- The U.S. Food and Drug Administration (FDA) released a statement August 29th pushing back against the recent California Prop 65 acrylamide ruling that requires cancer warning labels on coffee. Acrylamide is one of dozens of chemicals listed under California's Safe Drinking Water and Toxic Enforcement Act of 1986, better known as Proposition 65. Acrylamide, forms in the many foods that turn brown when roasted or baked at high temperatures. Bread, toast, chocolate, french fries, cookies, coffee are examples of foods that contain acrylamide.

The FDA warns California that Prop 65 as it applies to coffee, "could mislead consumers to believe that drinking coffee could be dangerous to their health when it actually could provide health benefits." FDA Commissioner Dr. Scott Gottlieb stated clearly what hundreds of scientists, the World Health Organization and the FDA itself have been saying for years: "Strong and consistent evidence shows that in healthy adults moderate coffee consumption is not associated with an increased risk of major chronic diseases, such as cancer, or premature death, and some evidence suggests that coffee consumption may decrease the risk of certain cancers."

“The California warning about cancer and it’s possible relationship to coffee is totally misplaced. Coffee actually lowers the risk of 6 common cancers." -Dr. Sanjiv Chopra

Post this

Dr. Sanjiv Chopra, professor of medicine and former Faculty Dean for Continuing Medical Education at Harvard Medical School, confirmed, "The California warning about cancer and it's possible relationship to coffee is totally misplaced. Coffee actually lowers the risk of 6 common cancers including cancer arising in the liver, which we primarily call 'liver cancer', metastatic prostate cancer, colon cancer, skin cancer, head and neck cancer, endometrial cancer. In three large-scale studies, people who drink coffee have lower total and cause-specific mortality." In addition, Dr. Stephen Gruber, director of the USC Norris Comprehensive Cancer Center stated, "We found that drinking coffee is associated with lower risk of colorectal cancer, and the more coffee consumed, the lower the risk."

Andrew Salisbury, Co-founder of Purity Coffee and an expert on coffee and health stated, "There are thousands of peer-reviewed studies that show the health benefits of coffee are profound. The application of Proposition 65 to coffee does a disservice to consumers trying to make food decisions that are good for their health. At Purity Coffee we make every decision based on health and want to advance the conversation about coffee and science."

The American Cancer Society also weighed in on coffee's potential health impacts, and coffee is included in a list of foods that fight cancer published by the American Institute for Cancer Research. Studies have repeatedly shown that in those who drink coffee regularly, there is evidence for lower rates or risks of several cancers:
Liver cancer
Colorectal cancer
Prostate cancer
Endometrial cancer
Head and neck cancer

For coffee drinkers who are sensitive to toxins, Purity Coffee is roasted to be low in acrylamide and high in antioxidants.

****

Purity Coffee was started in 2015 by Andrew Salisbury and Missy and Jon Butcher. The Purity Coffee mission is to craft coffees that are specifically developed for health. Purity Coffee is certified organic Arabica coffee that has been independently lab-tested to deliver the optimum level of healthy antioxidants using well-designed roast curves, while it is also tested to be mold, yeast, mycotoxin and pesticide free.

For interviews with Dr. Sanjiv Chopra or Andrew Salisbury
Contact:
Erin Berrios
erin(at)PurityCoffee(dot)com
323-393-3746
http://www.puritycoffee.com
http://www.facebook.com/mypuritycoffee
http://www.twitter.com/purity_coffee
http://www.instagram.com/purity_coffee

SOURCE Purity Coffee

Related Links

http://www.puritycoffee.com

Modal title

Dr. Sanjiv Chopra
Dr. Sanjiv Chopra
Andrew Salisbury, Co-founder Purity Coffee
Andrew Salisbury, Co-founder Purity Coffee
Dr. Sanjiv Chopra Andrew Salisbury, Co-founder Purity Coffee

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.